Bost Inno: August M&A roundup: Trillium’s redemption and Reebok’s $2.5B sale

The unofficial end of summer is upon us. Some major deals rounded out the summer, including Pfizer’s acquisition of Trillium Therapeutics‘ at a 200% premium. Trillium went from being at risk of getting delisted from the Nasdaq to being bought by one of the biggest pharmaceutical giants.

Read the full article on Bost Inno.

Interested in Becoming a Community Partner?

The Fourth Industrial Revolution may be one of the most important conversations of our time.

Help bring next-generation technologies to the US by becoming a Greater Boston Community partner.